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2 Vasopressin (VP) is a neurohypophyseal peptide best known for its role in maintaining osmotic 
3 and cardiovascular homeostasis. The main sources of VP are the supraoptic and paraventricular 
4 (PVN) nuclei of the hypothalamus, which co-express the vasopressin V1a and V1b receptors 
5 (V1aR and V1bR). Here we investigate the level of expression of VP and VP receptors in the 
6 PVN of borderline hypertensive rats (BHRs), a key integrative nucleus in neuroendocrine 
7 cardiovascular control. Experiments were performed in male BHRs and Wistar rats (WR) 
8 equipped with radiotelemetry device for continuous hemodynamic recordings, under baseline 
9 conditions and after saline load without or with stress. The autonomic control of the circulation 
10 was evaluated by spectral analysis of blood pressure (BP) and heart rate (HR) variability and 
11 baro-receptor reflex sensitivity (BRS) using the sequence method. Plasma VP was determined 
12 by radioimmunoassay, and VP, V1aR and V1bR gene expression by RT-qPCR.  Under baseline 
13 conditions, BHRs had higher BP, lower HR and enhanced BRS in respect to WRs. BP and HR 
14 variability was unchanged. In the PVN, overexpression of VP and V1bRs genes were found 
15 and plasma VP was increased. Saline load downregulated V1bR mRNA without affecting VP 
16 mRNA expression, plasma VP and the BP. Adding stress increased BP, BP and HR low 
17 frequency sympathetic spectral markers, decreased plasma VP without altering the level of 
18 expression of VP and VP receptors in PVN. It follows that overexpression of VP and V1bR in 
19 the PVN is a characteristic trait of BHR, and that sympathetic hyperactivity underlies stress-
20 induced hypertension.
21
22 KEY WORDS: Vasopressin, vasopressin receptors, borderline hypertension, stress, 
23 hypothalamic paraventricular nucleus
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2 Vasopressin (VP) is a neurohypophyseal peptide hormone engaged in an abundance of 
3 physiological and behavioural regulatory processes, but it is best known for its importance in 
4 maintaining osmotic and cardiovascular homeostasis. The main sources of VP in the brain are 
5 the supraoptic (SON) and paraventricular (PVN) nuclei of the hypothalamus 1,2. It is well 
6 established that PVN is a key integrative site for neuroendocrine and autonomic responses 
7 relevant for cardiovascular regulation. Large magnocellular neurons (MCNs) of the PVN 
8 synthesize VP, which is axonally transported to the neurohypophysis for systemic secretion 1,2. 
9 In the periphery, VP fosters water reabsorption in the kidneys and vasoconstricts blood vessels 
10 to increase peripheral resistance supporting circulation 3. Smaller parvocellular neurons of the 
11 PVN comprise a neuroendocrine portion which synthesizes VP and releases it in to the 
12 hypophyseal portal circulation, and a pre-autonomic neuronal subgroup responsible for the 
13 sympathetic nervous system activation that contributes to hypertension 4. These latter neurons 
14 modify sympathetic outflow by virtue of projections to the brain stem autonomic nuclei in the 
15 rostroventral part of the medulla (RVLM vasomotor neurons) and the intermediolateral column 
16 of the spinal cord (IML), enabling them to modulate cardiovascular and renal homeostasis 5. 
17 VP is also released from somata and dendrites of MCNs where it performs auto-regulation via 
18 specific co-localised vasopressin receptors (V1aR and V1bR) 6,7. Osmotic challenges have 
19 been shown to modify the expression of V1aRs, modulate VP release and sympathetic outflow 
20 in normotensive rat strains 8-10. V1bRs in the PVN were also found to be implicated in the 
21 blood pressure (BP) increase caused by VP microinfusion into the PVN 11. However, the 
22 possible roles of VP, V1aRs and V1bRs in the PVN in the pathogenesis of borderline 
23 hypertension has not been elucidated.
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1 We hypothesized that changes in the gene expression of V1aR and V1bR receptors in 
2 PVN may modulate VP gene expression and release and thus contribute to the genesis of 
3 borderline hypertension in rats (BHR) and their susceptibility to develop overt hypertension 
4 when exposed to repeated environmental stressors 12. Therefore, we evaluated the gene 
5 expression of VP, V1aR and V1bR in the PVN of BHRs as well as plasma VP and 
6 cardiovascular autonomic control under baseline physiological condition and when submitted 
7 to a 24-weeks long salt load with and without repeated stress. 
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2 All experimental procedures in this study conform to the guidelines from Directive 
3 2010/63/EU of the European Parliament on the protection of animals used for scientific 
4 purposes, as well as UK Animal Act 1986. The experimental protocol was approved by the 
5 School of Medicine University of Belgrade Ethics review board (# 323-07-04083/2016-05/7), 
6 and all studies involving animals comply with the ARRIVE guidelines for reporting 
7 experiments involving animals 13,14.
8
9 Animals 
10 Two strains of rats, Wistar rats (WR) and BHRs, were included in the study. BHR were 
11 produced in a local animal facility as an F1 generated by crossbreeding spontaneously 
12 hypertensive rat (SHR) females and normotensive WR males. All animals were matched 
13 regarding their age (12 weeks old) and weight (280-330 g), and were housed in a controlled 
14 environment (12 h/12 h light-dark cycle, temperature 21±2◦C and humidity 65±9%) with 
15 access to standard food pellets (0.2% sodium content; Veterinarski zavod, Subotica, Republic 
16 of Serbia) and tap water or 0.9% saline solution ad libitum. The number of rats enrolled in 
17 experimentation was determined in ‘Power Sample Size Calculation’ software 
18 (http://biostat.mc.vanderbilt.edu/twiki/bin/view/Main/PowerSampleSize) for power of 90% 
19 and type I error probability of 0.05. 
20
21 Implantation of radiotelemetry probe in abdominal aorta 
22 Animals were anesthetized using a combination of ketamine (100 mg•kg−1, I.M.) and 
23 xylazine (10 mg•kg−1, I.M.). The depth of anesthesia was verified by the lack of corneal and 
24 pedal reflexes, at the beginning and throughout the surgery. Rat body temperature was 
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1 maintained by a heating pad (Harvard Apparatus, Holliston, MA, USA). Following medial 
2 abdominal 3 cm-long incision and intestine retraction, a catheter tip of radiotelemetry device 
3 (TA11-PA C40; DSI, Transoma Medical, St Paul, MN, USA) was inserted into aorta, fixed 
4 with 3M VetbondTM and tissue cellulose patch (DSI, Transoma Medical). Perioperatively, rats 
5 were treated with gentamicin (25 mg•kg−1, i.m.) and carprofen (5 mg•kg−1 daily, s.c.) to prevent 
6 secondary bacterial infections and to reduce pain, respectively. Postoperatively, animals were 
7 housed individually (30 × 30 × 30 cm Plexiglas cage) in a separate surrounding under 
8 controlled laboratory conditions. They were monitored every day until full recovery.
9
10 Experiment design
11 Fourteen days following surgery rats were fully recovered and randomly allocated in 
12 four groups subjected to different protocols. In group 1, Wistar rats drinking tap water were 
13 kept under baseline physiological conditions for 24 weeks. In group 2, BHRs drinking tap water 
14 were kept under baseline conditions for 24 weeks. In group 3, BHRs were drinking 0.9% saline 
15 solution for 24 weeks, while in group 4, BHRs were drinking 0.9% saline solution and were 
16 exposed to repeated heterotypic stressors to minimize conditioning, also for 24 weeks. 
17 Heterotypic stress was produced by applying alternating stress batteries. Battery 1 lasted 4 
18 weeks: crowding stress (rats were housed in a reduced living space: 70 cm2/100g body weight) 
19 plus shaking stress (200 cycles/min for 30 min), for 6 days per week. Battery 2 lasted 6 weeks: 
20 isolation in opaque Plexiglas cages (300 cm2/100g body weight) plus inclination at 40º for 60 
21 minutes followed by 2-min-long air jet directed to the top of ratsʹ head, for 6 days per week. 
22 Battery 1 was repeated for 3 times, and battery 2 was repeated for 2 times, in total for 24 weeks. 
23 On each seventh day (day without exposure to stress), SBP, DBP, HR, BRS and spectral 
24 parameters were monitored and shown after completion of each stress battery.
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1 Cardiovascular signal processing and analysis
2 Arterial BP was digitalized at 1000 Hz in Dataquest A.R.T. 4.0 software, (DSI, 
3 Transoma Medical). Systolic (SBP) and diastolic BP (DBP) and pulse interval (PI) or its 
4 inverse heart rate (HR) were derived from the arterial pulse pressure wave as maximum, 
5 minimum and dP/dtmax inter-distance, respectively. 
6
7 Evaluation of the spontaneous baroreceptor reflex by the sequences method 
8 The method is explained in detail elsewhere 15. A stream of, at least four, consecutively 
9 increasing or decreasing SBP values and PI values delayed by three, four or five beats with 
10 respect to SBP, were considered as baro-receptor reflex sequence 16. The following parameters 
11 were calculated as follows:
12  Baroreceptor reflex sensitivity (BRS, ms•mmHg−1) as linear regression coefficient 
13 averaged over all identified sequences (PI = BRS•SBP + const., where fitting of the 
14 curve is done in a least square method); 
15  Baroreceptor effectiveness index (BEI) as ratio of the number of SBP-PI sequences 
16 versus number of SBP ramps
17  Operating range (OR) as a rectangle surface covering 95% of SBP-PI sequences.
18  Set Point (SP) as a median of all SBP-PI sequences.
19
20 Spectral analysis of BP and HR
21 Spectral analysis of SBP, DBP and HR based on fast Fourier transformation, was 
22 performed after linear de-trending, nine-point Hanning window filtering and resampling at 
23 20Hz 17. Spectra were obtained on 30 overlapping 2048 points time series of SBP, DBP and 
24 HR. The BP (mmHg2) and HR (bpm2) spectral powers were calculated for the whole spectrum 
25 (0.0195–3Hz) and in the three frequency ranges: very low frequency (VLF, 0.0195–0.195 Hz), 
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1 low frequency (LF, 0.195–0.8Hz) and high frequency (HF, 0.8–3Hz). The LF SBP and LF 
2 DBP and LF/HF HR are recognized autonomic markers in both clinical 18,19 and experimental 
3 practices 20 
4 Blood and tissue collection for evaluation of plasma VP and mRNA expression of VP, V1aR 
5 and V1bR in the rat PVN 
6 At the end of the last recording session rats were euthanized using guillotine (Harvard 
7 Apparatus, Holliston, Massachusetts, USA) for fast decapitation. The blood was collected from 
8 the trunk in chilled plastic tubes with heparin and the brains were removed and snap frozen 
9 with powdered dry ice. Plasma was obtained after centrifugation (20 min, 1600 g, 4°C) and 
10 stored at -80 °C for up to six months before the hormone extraction and lyophilisation. 
11 Lyophilised plasma was stored at -20 °C for six months until the radioimmunoassay.
12 The specific antibody for VP radioimmunoassay was obtained from Peninsula (T4561, 
13 San Carlos, CA, USA). The VP extraction and measurements were performed by using the 
14 specific radioimmunoassay techniques that were previously described by Husain et al 21. 1973. 
15 The VP measurement was performed in duplicate. The radioimmunoassay sensitivity range 
16 was from 0.4 to 32.0 pg/ml and intra- and inter-assay coefficients of variation were 7.9–9.75%, 
17 respectively.
18 By using a cryostat (Leica Microsystems CM1900, Leica Microsystems, Nussloch 
19 GmbH, Nussloch, Germany), 60 μm caudal-rostral brain slices were taken and stained with 
20 Toluidine blue (1% in 70% ethanol, Sigma-Aldrich Co. Ltd., Poole, Dorset, UK) for mapping 
21 and verification  of the hypothalamus 22. Both left and right PVN unstained tissue were punched 
22 taking  1 mm in diameter, using a 15-G Sample Corer (Fine Science Tools Inc., Foster City, 
23 CA, USA, cat.no 18035-01), and stored in RNase-free tubes at −80°C.
Page 8 of 33




1 RNA extraction 
2 Tissue samples were homogenized in 1 mL TRIzol reagent (Invitrogen, Thermo Fisher 
3 Scientific, Waltham, MA USA) by vortexing for 30 s. Samples were centrifuged at 12000 rpm 
4 for 12 minutes at 4°C.  Supernatants were aspirated by pipette into new tubes, while the pellet 
5 of cellular debris was discarded. Extraction was performed with 200 μL chloroform (Sigma-
6 Aldrich Co. Ltd.), added to each sample followed by vortexing. After 2-3 minutes of standing 
7 at room temperature, samples were centrifuged for 15 min, at 12 000 rpm, at 4°C. Aqueous 
8 upper phase, containing the RNA were decanted into fresh tubes; without disturbing the 
9 interphase or lower organic phase in which both the DNA and proteins were located. Total 
10 RNA from aqueous phase was then precipitated with 1 volume (~350 μL) of ethanol (EtOH 
11 100% v/v), and purified using the RNeasy Mini Kit (Qiagen, Qiagen Ltd., Manchester, UK) 
12 according to manufacturer’s protocol. 
13
14 cDNA synthesis
15  cDNA synthesis was performed using QuantiTect Reverse Transcription Kit (Qiagen, 
16 Qiagen Ltd., Manchester, UK) using 100 ng of input RNA. cDNA samples were then diluted 
17 to a concentration of 2 ng·μL−1 for use in real time qPCR. 
18
19 Real time quantitative polymerase chain reaction (qPCR) and data analysis
20  Primers for the housekeeping gene RPL19 (Ribosomal protein L19: 5′-
21 GCGTCTGCAGCCATGAGTA-3′ and 5′-TGGCATTGGCGATTTCGTTG-3′) were used to 
22 allow normalization of receptor expression between samples. Other primers for rat genes used 
23 in this study were VP (5′-TGCCTGCTACTTCCAGAACTGC-3′ and 5′-
24 AGGGGAGACACTGTCTCAGCTC-3′) synthetized by Eurofins MWG Synthesis GmbH, 
25 Ebersberg, Germany, V1aR (Rn Avpr1a 1 SG QuantiTect Primer Assay, QT00402990,NM 
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1 053019) obtained from Qiagen (Qiagen, Qiagen Ltd., Manchester, UK), V1bR (5′-
2 TGCCACATTCCTGGAGTACCT-3′, 5′-AGGACGGTTAACCAAGTAG TGAGATG-3′) 
3 provided by Invitrogen. All primers were designed using GenBank 
4 (https://www.ncbi.nlm.nih.gov/genbank/). Analysis was performed using an Applied 
5 Biosystems Viia7 Real Time PCR System (Applied Biosystems, Foster City, CA, USA) and 
6 processed using ViiA 7 Software v1.1 (Applied Biosystems, Foster City, CA, USA). The Δ 
7 cycle threshold (ΔCt = sample gene Ct − housekeeper gene Ct) was calculated for each sample 
8 and then exponentiation was applied to each sample (Power 2).
9
10 Drugs
11 Ketamine (Ketamidor), xylazine (Xylased®) and carprofen (Rimadyl®) were 




16 Results are presented as mean value ± standard error of the mean. BP, HR, spectral and 
17 baroreceptor reflex  parameters statistical differences between WR and BHR strain were 
18 estimated using Student’s T-test (two-sample T-test)  in SPSS Statistics v.20 software (IBM 
19 Corporation, NY, USA). qPCR data was analysed by One way ANOVA followed by Tukey 
20 post hoc, while data collected during the follow-up period were assessed by ANOVA for 
21 repeated measures within experimental groups in SPSS Statistics v.20 software. Mixed Effect 
22 Regression model was used to compare data between different experimental groups overtime 
23 in R-3.5.0 software (The R Foundation for Statistical Computing, Vienna, Austria). Statistical 
24 significance was considered at p ‹ 0.05.
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2 Plasma VP and expression of the VP, V1aR and V1bR genes in the PVN of WR and BHR under 
3 baseline conditions and following saline loading with or without stress 
4 Plasma VP was increased in BHRs under baseline physiological conditions in respect 
5 to WRs. (Figure 1). BHRs exhibited a three-to-four-fold increase of VP and V1bR mRNA 
6 expression levels in the PVN as compared to WRs while V1aR mRNA levels did not change 
7 (Figure 1).
8 Exposure of BHRs to saline load did not affect plasma VP concentrations nor VP and 
9 V1aR mRNA levels, but reduced V1bR mRNA levels with respect to BHR controls kept under 
10 baseline conditions (Figure 1). Exposure of salt loaded BHRs to heterotypic stressors decreased 
11 plasma VP concentration compared to BHR controls and salt loaded BHRs. In stressed rats VP, 
12 V1aR and V1bR mRNA levels did not change and were comparable to BHR controls (Figure 
13 1).
14
15 BP, HR, their short-term variability and the baroreceptor reflex in BHRs and WRs under 
16 baseline conditions
17 Under baseline conditions, BHRs exhibited higher SBP, DBP and lower HR values 
18 compared to WRs (Table 1). Spectral analysis of BP and HR short-term variability revealed no 
19 differences between the experimental groups (Figure 2). BRS and OR of BHRs were increased 
20 with respect to WRs under baseline physiological conditions and the baro-receptor reflex was 
21 re-set toward higher SBP values (Table 1).  
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1 BP, HR, their short-term variability and BRS in saline loaded BHRs with or without exposure 
2 to stress
3 Saline load alone did not affect SBP and DBP, but it decreased HR in respect to baseline 
4 values. In these rats BRS did not change overtime in respect to baseline values and in respect 
5 to BHR controls (Figure 3). Saline loaded BHRs exposed to stress showed a statistically 
6 significant increase of SBP over time with respect to baseline values and BHRs controls. DBP 
7 increase did not reach statistical significance. In these rats, BRS also increased whilst HR 
8 decreased over time in respect to baseline conditions (Figure 3). 
9 In saline loaded BHRs autonomic spectral markers indicate a reduction of sympathetic 
10 influences on the blood vessels and the heart: LF-SBP and LF-DBP decreased over time with 
11 respect to baseline conditions, and LF-HR and LF/HF-HR were lower compared to BHR 
12 controls. In contrast, autonomic spectral markers LF-SBP and LF-DBP and LF/HF-HR were 
13 enhanced in saline loaded and stressed BHRs with respect to BHR controls (Figure 4). 
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2 For the first time to our knowledge, we have described strain specific differences in VP 
3 and its receptors mRNA within the PVN of BHRs compared with normotensive controls. Under 
4 baseline conditions, BHRs exhibit elevated mean values of SBP, DBP, reduced HR and 
5 increased BRS, operating range and baroreceptor reflex resetting with respect to control WR. 
6 In BHRs qPCR analysis of the PVN revealed increased V1bR and VP gene expression and VP 
7 plasma concentration was increased. Saline load did not affect BP, BRS, plasma VP and VP 
8 gene expression in BHRs. However, V1bR gene expression decreased. When BHRs were 
9 exposed to saline load plus stress they developed overt hypertension and had decreased plasma 
10 VP. In these rats spectral markers reflecting sympathetic hyperactivity to blood vessels (LF-
11 BP) and the heart (LF/HF HR) were enhanced.  Neither VP nor VP receptor gene expression 
12 in the PVN were changed in these rats.
13 The BHR is the first filial offspring of crosses between SHRs and normotensive Wistar 
14 rats and thus possesses genetic information from both the normotensive and the hypertensive 
15 parent. The aetiology of borderline hypertension is not well understood and is different from 
16 genetic hypertension (SHR). Our present results suggest the involvement of VP in the 
17 pathogenesis of borderline hypertension. It has been documented previously that VP both 
18 centrally and peripherally contributes, but does not play a key role in the pathogenesis of 
19 genetic hypertension 23-28. It has also been suggested that increased expression of VP mRNA 
20 in the PVN and SON is a constitutive trait of SHR, found in the pre-hypertensive stage in the 
21 SHR28. VP released from the magnocellular division of the PVN into the systemic circulation 
22 targets V2Rs in the collecting ducts of the kidneys to conserve water 29, and V1aRs in blood 
23 vessels to increase peripheral resistance. These effects of VP are important for support of the 
24 circulation and are lifesaving under hypovolemic and hypotensive conditions 30-32. At a molar 
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1 level, VP has been shown to be the most potent vasoconstrictor 33. However, when applied 
2 systemically to normovolemic and normotenisve rats, VP only moderately increases BP 
3 because it increases the BRS and more effectively decreases HR, which then more efficiently 
4 opposes increased peripheral resistance 34. The effect of VP on the BRS was found to be 
5 mediated via the area postrema, a structure lacking a blood brain barrier, which is abundantly 
6 connected to the nucleus of the solitary tract (NTS), where baro-receptor reflex afferents 
7 terminate 35. There is pharmacological evidence that both types of VP receptors, V1a and V2, 
8 are involved in BRS modulation in the rat area postrema 36-38. Thus, in present experiments, 
9 increased expression of the VP mRNA in the PVN of BHR rats may result in increased 
10 synthesis and release of VP into the blood. This may increase peripheral resistance and at the 
11 same time sensitize the baro-receptor reflex to reduce HR more effectively and keep BP in the 
12 borderline range. It is of interest to emphasize here that the baro-receptor reflex is one of the 
13 key controllers of VP release39. However, in BHRs exhibiting chronically increased BP the 
14 baro-receptor reflex fails to suppress VP release into the circulation regardless increased 
15 sensitivity. This could be due to the resetting of the baro-receptor reflex to higher BP values 
16 and no changes in BEI (Table 1). The concomitant increase of BRS and of baro-receptor reflex 
17 operating range in borderline hypertension may lead to its exhaustion, when exposed to 
18 environmental stressors.
19 Our experiments suggest that vasopressin V1bR could be involved in the autocrine 
20 regulation of VP release in BHRs under baseline physiological conditions.  V1bRs are 
21 abundantly expressed in the PVN and are co-localized with V1aR in VP secreting neurons, in 
22 both magnocellular and parvocellular divisions 6,40. Gouzènes et al 6 provided evidence in vivo 
23 that VP released somato-dendritically by exocytosis, regularizes the firing pattern of MCNs to 
24 best fit the axonal release of VP to physiological demand. Vesicles containing VP prepared for 
25 somatodendritic release are positive for both V1aR and V1bR receptors. A number of reports 
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1 mention V1aR in autocrine regulation of VP release 41. In rats, Hurbin et al 41 have shown that 
2 dehydration up-regulates the V1aR mRNA in MCNs and V1aR receptor content in exocytotic 
3 granules.  They also noted a down regulation of V1aR mRNAs in MCNs, and V1aR receptor 
4 content in exocytotic granules during water over-load. Son and colleagues 8 further 
5 demonstrated that V1aRs located on neurons in the parvocellular division of PVN are 
6 stimulated by VP released by MCNs in the magnocellular division to provide an integrated 
7 humoral and neurogenic response to osmotic challenge. Ribeiro and colleagues 9 observed that 
8 V1aRs in the PVN are involved in the mediation of sympatho-excitation during salt load in 
9 normotensive rats. Lozić and coworkers 10 investigated the role of V1aRs in the PVN during 
10 stress and showed that they reduce BRS under baseline physiological conditions, and increase 
11 the neurocardiogenic stress response. Our present results do not indicate a change in V1aR 
12 expression in the PVN of BHRs under baseline conditions, when exposed to saline load and 
13 when exposed to saline load plus stress. Rather, our results point to increased expression of 
14 V1bR as a possible mechanism involved in autocrine positive feed-back control of VP release 
15 in BHR.
16 In the parvocellular division of the PVN, VP is expressed in a number of neurons that 
17 project to the brainstem vasomotor centre in the RVLM and to pre-ganglionic sympathetic 
18 neurons located in the IML column of the spinal cord, where V1aRs are found 5. In clinical and 
19 experimental practice, sympathetic outflow to the blood vessels and the heart can be assessed 
20 indirectly by autonomic spectral markers 20. In the present experiments no changes in LF-BP 
21 and LF/HF HR spectral markers were observed under baseline conditions in BHRs (Figure 2), 
22 suggesting that increased expression of VP and V1bR in the PVN occurs in the magnocellular 
23 division and does not alter baseline neurogenic cardiovascular control in BHRs.
24 The concept that hypertension derives from an interaction between genetic and 
25 environmental factors was first proposed by Folkow 42. Of the environmental factors, dietary 
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1 sodium intake and environmental (psychosocial) stress are considered important. DiBona and 
2 Rios 43 have shown that intravenous isotonic saline infusion exaggerates natriuresis in SHR 
3 due to increased renal sympathetic nerve activity (RSNA) withdrawal. In SHR and Dahl rats 
4 Koepke and colleagues 44,45 have further shown that increased dietary sodium intake augments 
5 efferent RSNA in response to environmental stress leading to greater renal vasoconstriction 
6 and profound antidiuretic and antinatriuretic response. They have also shown that BHR rats 
7 exposed to high sodium intake have a response similar to SHR rats, whilst BHRs exposed to 
8 low sodium intake (up to 1% w/v) does not  and respond like normotensive controls 46. This is 
9 in line with our findings that BHRs drinking saline (corresponding to low sodium intake) 
10 exhibited sympathetic withdrawal, as documented indirectly by LF-BP spectral decrease, 
11 allowing effective natriuresis, as in normotensive rats. A decrease in V1bR in the PVN of salt 
12 loaded BHRs also suggests removal of positive feed-back autocrine control on VP 
13 synthesis/release. Altogether, these data exclude the possibility that hydromineral imbalance 
14 occurs in BHR exposed to saline load contributing to BP dysregulation.
15 In present experiments, BHRs drinking isotonic saline and exposed to heterotypic 
16 stressors for 24 weeks showed higher BP values with respect to baseline conditions and BHR 
17 controls throughout the observation period. The lack of statistical significance in DBP increase 
18 could be due to improved BP control by baro-receptor reflex since BRS increased over time, 
19 though partial habituation cannot be excluded. Compared to BHR controls, SBP, LF-SBP, LF-
20 DBP and LF/HF-HR constantly increased to reach highest values by the end of the stress 
21 protocol. An increase of LF-BP and LF/HF HR in present experiments indicates increased 
22 sympathetic outflow respectively to the blood vessels 47,48 and the heart 48-51 suggesting that 
23 this is the mechanism underlying stress-induced systolic hypertension. The possibility that 
24 autonomic spectral markers reflect increased sensitivity of peripheral vasculature and cardiac 
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1 tissue to catecholamines is unlikely since saline load below 1% NaCl has been shown not to 
2 modulate cardiovascular tissue reactivity to catecholamines in the BHR 52.
3 Our results do not support a role of peripheral VP in stress-induced hypertension in 
4 BHRs. Stress did not affect the level of expression of V1bR and VP in the PVN in respect to 
5 baseline conditions. Moreover, in BHRs exposed to saline load and stress, there was a decrease 
6 in plasma VP. This is not an unexpected finding since stressors provoking strong emotional 
7 reactions have been reported to inhibit systemic VP secretion 53. In our experiments, BHRs 
8 were exposed to air-jet stress that induces startle and a panic reaction. We also changed the 
9 housing of BHRs and introduced another emotional, novelty paradigm. The present 
10 experiments show that the combination of these two paradigms reduces VP secretion without 
11 affecting its mRNA steady-state abundance. Nonetheless we cannot exclude the possibility that 
12 stress-induced hypertension also supressed VP release.  It is of note to mention that 
13 concomitant saline load with stress blunts the HPA axis responsiveness to stress 54. 
14 The present study has a limitation that needs to be addressed. The main drawback 
15 is the lack of data on V1aR and V1bR receptor protein levels in the PVN of both WR and 
16 BHRs under different experimental conditions. V1aR and V1bR are G protein 
17 coupled receptors (GPCRs) and as such they are important regulators of cellular 
18 function. As GPCR mRNA level and protein do not necessarily correlate, detection at 
19 protein level is important. GPCRs can be identified either using specific radioligands or 
20 antibodies. However, suitable radioligands for V1aR and V1bR are missing, while the 
21 selectivity of antibodies is doubtful due to great structural homology (up to 85 %) between 
22 V1aR, V1bR and oxytocin receptors 55, all found in the PVN of rats. The lack of antibody 
23 selectivity to vasopressin and oxytocin receptors is not an exception, but rather a rule for 
24 GPCR antibodies 56. And a number of reports discourage the use of antibodies for GPCR 
25 protein detection 57-62. At present state of the art, it seems that the expression of mRNA is 
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1 the only reliable approach for GPCRs assessment. Thus, we have used this technology to 
2 quantify changes in the expression of the V1aR and V1bR receptors at the level of steady-
3 state mRNA abundance (see Figure 1).
4 V1aR and V1bR cell surface density is dynamic and changes under different 
5 physiological conditions due to either changes in mRNA expression or receptor 
6 internalization involving β-arrestin or clathrin-coated vesicles, marking the end of 
7 peptide action 63. Internalized receptors have different faiths. They can undergo 
8 degradation and reduces protein level or recycle to the cell surface without affecting the 
9 protein level. V1aR have been shown to recycle rapidly, and V1bR have been reported to 
10 be preponderantly located in the cytoplasm even unstimulated 64, and none are being 
11 degraded following internalization. Therefore, we believe that it is unlikely that the 
12 steady-state abundance of the V1aR and V1bR is not related to mRNA level in this study.
13 In conclusion, the present results show, for the first time, that over-expression of VP 
14 and V1bR genes in the PVN is a characteristic trait of the borderline hypertension in the rat. 
15 Overexpression of VP and of V1bRs in the PVN does not seem to modulate neurogenic control 
16 of the circulation in BHRs under baseline conditions, but is associated with increased plasma 
17 VP, that may act at the same time to increases periphera  resistance and to increase BRS 
18 preserving BP at borderline level. Exposure of BHRs to prolonged isotonic saline load and 
19 stress increased sympathetic outflow to blood vessels and the heart inducing overt 
20 hypertension. At the same time plasma VP decreased and the expression of VP, V1bR and 
21 V1aR genes in the PVN was unaffected. This suggests that sympathetic hyperactivity and not 
22 peripherally released VP underlies stress-induced hypertension in BHRs.
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1 Figure 1. Plasma VP and VP, V1aR and V1bR in the PVN of WR and BHR under baseline 
2 conditions and following saline loading with or without stress. Note the increase of plasma 
3 VP, VP and V1bR gene expression in the PVN of BHRs under baseline conditions with respect 
4 to WRs. Saline decreased V1bR gene expression. Adding stress reduced plasma VP without 
5 affecting VP, V1aR and v1bR gene expression. In this and the following figures WR-Wistar 
6 rats; BHR-borderline hypertensive rats; VP-vasopressin; V1aR-vasopressin receptor type 1a; 
7 V1bR-vasopressin receptor type 1b. Values are mean of at least six rats ± s.e.m.. *p<0.05; 
8 **p<0.01vs. WR baseline; † p< 0.05; †† p<0.01 vs. BHR baseline; ‡‡ p<0.01 vs. BHR saline 
9 (One-Way ANOVA followed by post hoc Tukey).
10
11 Figure 2. Autonomic spectral markers in BHRs and WRs under baseline conditions. In 
12 this and the following figures LF SBP-low frequency systolic blood pressure spectral 
13 component; LF DBP-low frequency diastolic blood pressure spectral component; LF HR-low 
14 frequency heart rate spectral component; LF/HF HR–low frequency to high frequency heart 
15 rate ratio. Values are mean of at least six experiments ± s.e.m. (Student’s T-test).
16
17 Figure 3.  BP, HR and BRS in BHRs exposed to saline load without or with stress. Mark 
18 the increase in SBP and BRS in BHRs exposed to saline solution plus heterotypic stress. HR 
19 was decreased in BHRs drinking saline with or without exposure to stress. Values are mean of 
20 at least seven rats ± s.e.m.. *p<0.05, *** p<0.001 (ANOVA for repeated measures) vs. 
21 baseline; †p<0.05 vs. control BHR group (Hierarchical linear regression).
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1 Figure 4. Autonomic spectral markers in BHRs exposed to saline load without or with 
2 stress. In saline loaded BHRs without exposure to stress LF SBP and LF DBP decreased over 
3 time. LF HR and LF/HF HR were lower compared to BHR controls. Note that LF SBP, LF 
4 DBP and LF/HF HR are higher in saline loaded plus stressed BHRs compared to BHR controls. 
5 Values are mean of at least seven rats ± s.e.m.. *p<0.05 (ANOVA for repeated measures) vs. 
6 baseline; †p<0.05; ††p<0.01 vs. control BHR group (Hierarchical linear regression).
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Table 1. BP, HR and baroreceptor reflex in BHRs and WRs under baseline conditions
WR BHR
SBP (mmHg) 115 ± 3 134 ± 3 **
DBP (mmHg) 82 ± 2 99 ± 2 **
HR (bpm) 321 ± 12 269 ± 6 ***
BRS (mmHg·ms) 1.1 ± 0.1 1.6 ± 0.2*
BEI 0.6 ± 0.03 0.63 ± 0.02
OR (ms·mmHg) 114.6 ± 36.5 205 ± 2.0 *
SP (mmHg) 105.1± 3.2 123.6±3.2**
Values are mean of experiments ± s.e.m..  SBP-systolic blood pressure; DBP-diastolic blood 
pressure; HR-heart rate; BRS-baro-receptor reflex sensitivity. BEI-baro-receptor effectiveness 
index; OR-operating range; SP-set point. **p<0.01, *** p<0.001 vs. WR.
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Figure 1. Plasma VP and VP, V1aR and V1bR in the PVN of WR and BHR under baseline conditions and 
following saline loading with or without stress. Note the increase of plasma VP, VP and V1bR gene 
expression in the PVN of BHRs under baseline conditions with respect to WRs. Saline decreased V1bR gene 
expression. Adding stress reduced plasma VP without affecting VP, V1aR and v1bR gene expression. In this 
and the following figures WR-Wistar rats; BHR-borderline hypertensive rats; VP-vasopressin; V1aR-
vasopressin receptor type 1a; V1bR-vasopressin receptor type 1b. Values are mean of at least six rats ± 
s.e.m.. *p<0.05; **p<0.01vs. WR baseline; † p< 0.05; †† p<0.01 vs. BHR baseline; ‡‡ p<0.01 vs. BHR 
saline (One-Way ANOVA followed by post hoc Tukey). 
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Figure 2. Autonomic spectral markers in BHRs and WRs under baseline conditions. In this and the following 
figures LF SBP-low frequency systolic blood pressure spectral component; LF DBP-low frequency diastolic 
blood pressure spectral component; LF HR-low frequency heart rate spectral component; LF/HF HR–low 
frequency to high frequency heart rate ratio. Values are mean of at least six experiments ± s.e.m. 
(Student’s T-test). 
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Figure 3.  BP, HR and BRS in BHRs exposed to saline load without or with stress. Mark the increase in SBP 
and BRS in BHRs exposed to saline solution plus heterotypic stress. HR was decreased in BHRs drinking 
saline with or without exposure to stress. Values are mean of at least seven rats ± s.e.m.. *p<0.05, *** 
p<0.001 (ANOVA for repeated measures) vs. baseline; †p<0.05 vs. control BHR group (Hierarchical linear 
regression). 
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Figure 4. Autonomic spectral markers in BHRs exposed to saline load without or with stress. In saline loaded 
BHRs without exposure to stress LF SBP and LF DBP decreased over time. LF HR and LF/HF HR were lower 
compared to BHR controls. Note that LF SBP, LF DBP and LF/HF HR are higher in saline loaded plus stressed 
BHRs compared to BHR controls. Values are mean of at least seven rats ± s.e.m.. *p<0.05 (ANOVA for 
repeated measures) vs. baseline; †p<0.05; ††p<0.01 vs. control BHR group (Hierarchical linear regression). 
308x195mm (300 x 300 DPI) 
Page 33 of 33
The Japanese Society of Hypertension
Hypertension Research
